Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

Simultaneous discoveries in art and science highlight humanity's shared creativity, problem-solving, and the ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This achievement is a reflection of our collective efforts and ...

A look at Intellia Therapeutics, Inc. and Editas Medicine, Inc., including their restructuring and pipeline prioritization. Read more about EDIT and NTLA stocks here.

Despite having its premiere cancelled due to the Los Angeles wildfires, “Unstoppable,” a new sports drama starring Jennifer Lopez, is now streaming on Prime Video. Emmy award winner ...

Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Editas Medicine (EDIT – Research Report) yesterday and set a ...

Meet Jennifer. She grew up in a home filled with criticism and rejection, leaving her with a fragile sense of self-worth. Although she loved God and was active in church, her relationship with Him ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu from Wells Fargo maintained a Hold rating on the ...